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Summary
Efg1 (a member of the APSES family) is an important
regulator of hyphal growth and of the white-to-opaque
transition in Candida albicans and very closely related
species. We show that in Candida parapsilosis Efg1 is
a major regulator of a different morphological switch at
the colony level, from a concentric to smooth morphol-
ogy. The rate of switching is at least 20-fold increased
in an efg1 knockout relative to wild type. Efg1 deletion
strains also have reduced biofilm formation, attenu-
ated virulence in an insect model, and increased sen-
sitivity to SDS and caspofungin. Biofilm reduction is
more dramatic in in vitro than in in vivo models. An
Efg1 paralogue (Efh1) is restricted to Candida species,
and does not regulate concentric-smooth phenotype
switching, biofilm formation or stress response. We
used ChIP-seq to identify the Efg1 regulon. A total
of 931 promoter regions bound by Efg1 are highly
enriched for transcription factors and regulatory
proteins. Efg1 also binds to its own promoter, and
negatively regulates its expression. Efg1 targets are
enriched in binding sites for 93 additional transcrip-
tion factors, including Ndt80. Our analysis suggests
that Efg1 has an ancient role as regulator of develop-
ment in fungi, and is central to several regulatory
networks.
Introduction
The transcription factor Efg1 plays a central role in regu-
lating morphology and virulence in the major human
fungal pathogen Candida albicans. It was first identified
as an inducer of pseudohyphal growth in Saccharomyces
cerevisiae, and subsequently shown to be required for
hyphal growth in C. albicans (Stoldt et al., 1997). Strains
carrying deletions of EFG1 fail to undergo a switch from
yeast to hyphal growth in response to most stimuli (Lo
et al., 1997; Stoldt et al., 1997; Sudbery, 2011) although
filamentation is increased under hypoxic conditions, and
when embedded in solid media (Doedt et al., 2004;
Mulhern et al., 2006).
Efg1 has many functions in C. albicans. It is required
for virulence in most infection models (Lo et al., 1997;
Chamilos et al., 2006; Pukkila-Worley et al., 2009). In addi-
tion, cells lacking EFG1 are unable to invade reconstituted
human epithelia, and endocytosis in epithelial and
endothelial cells is reduced (Weide and Ernst, 1999;
Dieterich et al., 2002).
The pleiotropic effects of Efg1 in C. albicans are related
to its pivotal role in several networks controlling morphol-
ogy and virulence. Efg1 is one of the core regulators of the
white-opaque switch, an epigenetic switch between two
genetically identical cell types. Efg1 is required for the
maintenance of the default white phenotype (Sonneborn
et al., 1999b; Srikantha et al., 2000). Switching to opaque
cells is strongly correlated with mating efficiency (reviewed
in Bennett and Johnson, 2005; Lohse and Johnson, 2009;
Morschhauser, 2010). White and opaque cells differ in
appearance; white cells are round or ellipsoid and opaque
cells are elongated with ‘pimples’ on the surface (Anderson
and Soll, 1987; Anderson et al., 1990). They also differ in
behaviour; for example, white cells are preferentially
phagocytosed by macrophages (Lohse and Johnson,
2008), and opaque cells do not release a chemoattractant
for leukocytes (Geiger et al., 2004). The two cells types
have significantly different transcriptional profiles (Tuch
et al., 2010). The white-opaque switch is regulated by a
network of transcription factors that includes Efg1, Wor1,
Wor2 and Czf1, together with the homeodomain mating
proteins a1 and alpha2 (Sonneborn et al., 1999b;
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Srikantha et al., 2000; Huang et al., 2006; Vinces et al.,
2006; Zordan et al., 2006; 2007).
Efg1 is also important for the growth of C. albicans cells
in communities, or biofilms, on plastic or cell surfaces. Cells
with an efg1 deletion form very loose biofilms on plastic
consisting mostly of yeast cells (Ramage et al., 2002),
and form defective biofilms on vaginal mucosa (Harriott
et al., 2010). Unlike many other biofilm regulators, Efg1 is
required for biofilm development under both normoxic and
hypoxic (low-oxygen) conditions (Stichternoth and Ernst,
2009). Even when cells do adhere to plastic, Efg1 is
required for tolerance to antifungal drugs such as azoles,
amphotericin B and caspofungin (Bink et al., 2012).
A recent analysis by Nobile et al. (2012) showed that
Efg1 is part of a network of six transcription factors that
regulates biofilm development in C. albicans. The six regu-
lators all control each other’s expression; up to five factors
bind to each promoter, and in addition each activates its
own synthesis. The network regulates expression of at
least 1000 genes, many of which are also expressed
during biofilm growth. Nobile et al. (2012) identified several
hundred intergenic regions bound by Efg1, and separately,
Lassak et al. (2011) showed that Efg1 binds to the promot-
ers of at least 53 genes in C. albicans yeast cells, including
several transcription factors. Binding of Efg1 is disrupted
and new binding sites appear during the yeast-to-hyphal
transition. The analysis of Nobile et al. (2012) suggests
that the biofilm regulatory network has evolved relatively
recently, and is likely to be restricted to C. albicans.
Among the species in the Candida clade [or CTG clade,
species in which CTG is translated as serine rather than
leucine (Santos and Tuite, 1995)], only C. albicans and
C. dubliniensis form hyphae, and white-opaque switching
appears to be restricted to these species plus their close
relative Candida tropicalis (Lohse and Johnson, 2009;
Morschhauser, 2010; Porman et al., 2011; Xie et al., 2012).
However, Efg1 is a member of the APSES family of pro-
teins that contain a conserved basic helix–loop–helix
domain (Stoldt et al., 1997). Other members of the family
are involved in repression of pseudohyphal growth in
S. cerevisiae (Ward et al., 1995), conidiation in Aspergillus
nidulans and Penicillium marneffii (Aramayo et al., 1996;
Borneman et al., 2002) and the formation of aerial hyphae
and conidiation in Glomerella cingulata (Tong et al., 2007)
and Wangiella dermatitidis (Wang and Szaniszlo, 2007).
We describe here the role of Efg1 in Candida parapsilo-
sis, a major human fungal pathogen that is a member of the
CTG clade and is particularly associated with infection of
premature neonates (Trofa et al., 2008; van Asbeck et al.,
2009). C. parapsilosis grows in yeast and pseudohyphal
forms but not as true hyphae, and although variations in
colony morphology have been observed (Lott et al., 1993;
Enger et al., 2001; Laffey and Butler, 2005; Kim et al.,
2006), no equivalent of white-opaque switching has been
identified. The C. parapsilosis species group also appears
to be completely asexual, and do not exhibit the parasexual
cycle observed in C. albicans, C. dubliniensis and C. tropi-
calis (Bennett and Johnson, 2005; Butler, 2010; Porman
et al., 2011; Sai et al., 2011). We show that Efg1 represses
a morphological switch from concentric to smooth colony
formation, and is also a repressor of filamentation in
hypoxic conditions. We use a combination of RNA-seq and
ChIP-seq to identify Efg1 targets. Efg1 directly regulates a
significant number of transcription factors, particularly
those with long promoter sequences. Targets of Efg1 are
also enriched in binding sites of other transcription factors.
In addition, we show that Efg1 is required for biofilm
development, and for virulence.
Results
Deleting EFG1 in C. parapsilosis
The EFG1 orthologue in C. parapsilosis was identified
using sequence comparison and synteny conservation
(Fitzpatrick et al., 2010). Both alleles in the diploid were
deleted using three different approaches. First, the alleles
were replaced with a recyclable nourseothricin-resistant
marker as described in Ding and Butler (2007). Second,
each allele was replaced with either LEU2 (from Candida
maltosa) or HIS1 (from C. dubliniensis) in an auxotrophic
background strain. The auxotrophic markers were ampli-
fied using either a long oligonucleotide (approach 2) or by
fusion PCR (approach 3), using methods similar to those
described by Noble and Johnson (2005) (Fig. S1). EFG1
was re-introduced into one deletion strain under the
control of the ACT1 promoter as shown in Fig. S1D. All
phenotypes were tested using knockouts from each
approach to ensure that they result from the loss of the
EFG1 gene and not to a secondary effect.
The most obvious result of deleting EFG1 is that it leads
to a dramatic increase in the level of morphological
switching observed at the colony level (Fig. 1A). Almost all
colonies of the C. parapsilosis type strain (CLIB214) are
a ‘wrinkled’ or ‘concentric’ morphology (composed of a
series of concentric rings). Switching to other morpholo-
gies occurs at a very low level (Lott et al., 1993; Enger
et al., 2001; Kim et al., 2006). However, the efg1 deletion
consists of a mixture of both concentric and smooth colo-
nies (Fig. 1A). When grown in culture, concentric colonies
give rise to > 10% of smooth colonies and smooth colo-
nies to > 12% concentric colonies. The switching rate
varies in the different knockouts (Table S1) but is always
significantly higher than the wild type, which has a switch-
ing rate of approximately 0.2% (concentric to smooth) and
2% (smooth to concentric). Two of the efg1 knockouts
(generated using the fusion PCR approach) switch
from concentric to smooth colonies at a very high rate
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Fig. 1. Efg1 regulates colony switching in C. parapsilosis. Both alleles of the EFG1 gene were deleted as described in Fig. S1.A. Wild-type
(CLIB214) cell cultures consist of mostly concentric colonies, whereas efg1Δ/ efg1Δ (LCP7 is shown here) have a mixture of concentric and
smooth colonies. The rate of switching between concentric and smooth cells varies, but can be as high as 81%, with a substantial number of
sectored colonies (Table S1). Re-introducing EFG1 reduces the switching rate (LCP7_RI). Cells from concentric colonies tend to be elongated,
whereas those from smooth colonies are more round and yeast-like.
B. Wild-type colonies are generally smooth in hypoxic conditions (1% oxygen), and do not form the concentric phenotype obvious in normoxia
(21% oxygen). Deleting both alleles of EFG1 (LCP7 is shown here) results in rough and spiked colonies in hypoxic conditions, with an
increase in elongated and pseudohyphal cells (Table S2). The arrows indicate the cell wall between a mother cell and a pseudohyphal bud.
The reconstituted strain is more similar to the wild-type phenotype. In normoxic conditions, few pseudohyphae are observed. The top panels
show colonies and the bottom panels show corresponding calcofluor white-stained cells for growth at 1% and 21% oxygen.
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(65–81%). None of strains deleted for just one EFG1
allele exhibited an increased switching rate (not shown).
We reintroduced EFG1 expressed from the ACT1 pro-
moter into one of the strains with the highest switching
rate (Fig. S1). EFG1 expression from this construct is
approximately the same level as in a heterozygous EFG1/
efg1 deletion strain (data not shown), and switching is
returned to wild-type levels (Fig. 1A, Table S1).
Individual cells of C. parapsilosis (particularly those
derived from the type strain CLIB214) are more elongated
than C. albicans or S. cerevisiae yeast cells (Fig. 1A and
B). However, we found that cells from the smooth colonies
tend to be more round and yeast like when grown
in normal atmospheric conditions (Fig. 1, Table S2).
Because EFG1 is reported to be a repressor of filamen-
tation in hypoxia in C. albicans, we also examined the
morphology of the C. parapsilosis efg1 knockouts in low-
oxygen conditions. As shown in Fig. 1B, growth in hypoxia
induces a novel ‘spiked’ morphology in colonies that is not
observed in the wild type, irrespective of the concentric/
smooth morphology, independent of the level of oxygen
available. However, when EFG1 is deleted, there is a
significant increase in the number of pseudohyphal cells
in hypoxic conditions (Fig. 1B, Table S2). Long chains of
cells are very evident. The structures are reminiscent of
hyphae, except that there is a cell wall between the
mother (yeast) cell and the first pseudohyphal bud (indi-
cated with arrows in Fig. 1B). Cells grown in liquid culture
have the same phenotype (not shown). The phenotype of
colonies of the efg1/ACT1-EFG1 complemented strain is
more similar to the wild type, and the percentage of pseu-
dohyphal cells is between that of the wild-type and the
deletion strain (Table S2).
Deleting EFG1 affects biofilm development
Candida parapsilosis grows as biofilms on indwelling
medical devices (Hawser and Douglas, 1994; Silva et al.,
2009; Melo et al., 2011). The biofilm architecture is sub-
stantially different from that observed for C. albicans,
although some of the same regulators are required. For
example, the transcription factor Bcr1 is required for
biofilm development in both species (Nobile et al., 2006;
Ding and Butler, 2007; Finkel and Mitchell, 2011).
However, the mechanism and targets are likely to be
different; the CFEM family members are targets of Bcr1 in
both, but have a role in biofilm development only in
C. albicans (Ding and Butler, 2007; Ding et al., 2011).
Efg1 is required for biofilm formation by C. albicans
(Ramage et al., 2002; Nobile et al., 2012). We therefore
tested its role in C. parapsilosis. Deleting EFG1 in C. par-
apsilosis reduces biofilm development irrespective of
colony morphology (Fig. 2). Both smooth and concentric
colonies carrying an efg1 deletion have reduced biofilm
formation on the surface of 24-well Nunc plates compared
with wild type, with smooth cells having a slightly more
pronounced defect. The phenotype is partially restored
by re-introducing EFG1. The differences were observed
using dry weight measurements of mature biofilms, and
also crystal violet staining of adhered cells (Fig. 2A). We
also determined the effect of deleting EFG1 on biofilms
developed in vivo, using one deletion strain (LCP1) in the
rat catheter model developed by Andes et al. (2004). As
shown in Fig. 2B, in vivo biofilms generated by smooth
cells carrying an efg1 deletion are mildly reduced. Con-
centric colonies deleted for EFG1 were not tested in vivo.
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Fig. 2. Efg1 regulates biofilm development by C. parapsilosis.
A. The in vitro biofilm mass of smooth and concentric colonies from
wild type (CLIB214), efg1Δ/efg1Δ deletion strains (including a
mixture of strains LCP2, LCP5 and LCP8) and the reconstituted
strain LCP7_RI was determined by measurement of dry weights.
The average ± standard deviation from three independent
measurements is shown. The panels below show biofilm growth on
24-well Nunc plates stained with crystal violet.
B. In vivo biofilms were developed in the rat catheter model.
Concentric wild-type (CLIB214) cells and smooth efg1/efg1 deletion
(LCP1) cells were allowed to develop for 24 h and then visualized
by SEM at two magnifications.
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Efg1 affects cell wall function
In C. albicans, Efg1 is a major regulator of cell wall genes
(Sohn et al., 2003; Zavrel et al., 2012). We therefore
tested the phenotype of the efg1 knockouts under condi-
tions of known cell wall stress. Figure 3 shows that knock-
ing out EFG1 confers sensitivity to SDS and caspofungin,
and reduces growth on calcofluor white. Both smooth and
concentric cells are more susceptible to stress, but the
phenotype of smooth cells is more dramatic.
Efg1 is required for virulence in C. parapsilsosis
In C. albicans, deleting EFG1, either alone or in combina-
tion with the transcription factor CPH1, results in greatly
attenuated virulence in infection of mice (Lo et al., 1997),
Caenorhabditis elegans (Pukkila-Worley et al., 2009),
Drosophila (Chamilos et al., 2006) and zebrafish (Chao
et al., 2010). We determined the effect of deleting EFG1
on the virulence of C. parapsilosis, using the insect Gal-
leria mellonella, which has been shown to be a good
model for candidiasis (Fallon et al., 2012).
We first confirmed that C. parapsilosis wild-type strains
are capable of killing G. mellonella larvae. Following infec-
tion, survival is reduced to approximately 20% within
100 h, compared with 100% survival for uninfected larvae
(Fig. 4A). Deleting EFG1 however significantly attenuates
virulence (Fig. 4A – two independent deletions were
tested). Interestingly, strains carrying only one intact EFG1
allele (either deleted for only one allele, or carrying only the
ACT1-EFG1 allele) have virulence levels between the
wild-type and the double-deletion strains (Fig. 4A). This is
similar to the intermediate biofilm phenotype described in
Fig. 1, and suggests that similar to C. albicans, deleting
one allele of EFG1 results in a haploinsufficiency pheno-
type (Zavrel et al., 2012).
To determine if deleting EFG1 also affects virulence in
mammalian systems, we tested the ability of C. parapsi-
losis to inflict damage on human PBMC-DM (peripheral
blood mononuclear cell-derived macrophages) (Fig. 4B).
Damage was measured by the release of Lactate Dehy-
drogenase (LDH). Deleting EFG1 reduces the release of
LDH after 24 h (not shown) and 48 h (Fig. 4B). Once
again, having only one intact EFG1 allele results in a
phenotype that is intermediate between the wild type and
efg1/efg1 deletions.
Identifying the targets of Efg1
We used a combination of chromatin immunoprecipitation
with next-generation sequencing (ChIP-seq) to identify
promoters that are directly bound by Efg1. We generated
a tagged version of Efg1 in a strain carrying a deletion of
one EFG1 allele. A MYC epitope tag was introduced just
5′ to the stop codon of Efg1 by homologous recombina-
tion, using tools developed for C. albicans (Lavoie et al.,
2008). Two independent constructs were confirmed by
PCR (Fig. S1). The strains carrying the tagged allele
remain in the concentric morphology, indicating that the
construct is biologically functional.
The immunoprecipitated bound targets were investi-
gated by next-generation sequencing using Illumina tech-
nology. Reads were mapped to the current annotation of
the C. parapsilosis genome (Guida et al., 2011) using
BWA (Li and Durbin, 2009). Three experimental samples
(from two independently tagged strains) and three control
(input) samples were used. Enriched peaks were identi-
fied using MACS2 (Zhang et al., 2008; Feng et al., 2012).
We used estimates of the Irreproducible Discovery Rate
(IDR) to incorporate statistical measurements of repro-
ducibility from multiple replicate samples (Landt et al.,
2012). A list of bound regions [ranked by π score, fold
YPD SDS Caspofungin
WT (c)
WT (s)
efg1Δ/efg1Δ (s)
efg1Δ/efg1Δ (c)
efg1Δ/ACT1-EFG1
 (c)
efg1Δ/ACT1-EFG1
(s)
Calcofluor White
Fig. 3. Deleting Efg1 increases sensitivity to cell wall stress. Three microlitres from serial dilutions in PBS was inoculated on YPD alone, and
YPD with SDS (0.04%), caspofungin (0.1 μg ml−1) and calcofluor white (12 μM). Strains include concentric (c) and smooth (s) colonies from
wild type (C. parapsilosis CLIB214), efg1Δ/efg1Δ deletion (LCP8) and the reconstituted strain (LCP7_RI).
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change and log10 of the adjusted P value (Xiao et al.,
2012)] is shown in Table S3.
Efg1 binds over large distances in intergenic regions,
often with more than one peak per region (Fig. 5). For
example, Efg1 extends over at least > 5 kb in the promoter
sequence of CZF1. For ranking purposes we chose a
single peak within each intergenic sequence, with the
highest ranking (π score, highlighted in pink in Fig. 5).
The experiments were highly reproducible, as shown by
the different colour tracks in Fig. 5. We also confirmed the
binding sites for six promoters using ChIP-PCR (Fig. 5).
Of 1246 peaks identified, 53 lie within coding sequences
and 38 are 3′ to two open reading frames, and were not
included in subsequent analyses. The remaining 1155
peaks were assigned to 931 promoters. Because 395 of
these regions are within divergent promoters, up to 1326
genes may be directly controlled by the transcription factor.
Gene Ontology analysis indicates that the target genes
are significantly enriched for regulatory proteins, including
transcription factors (P value = 3.47e-7, Table S3C). At
least 93 transcription factors are direct targets, including
several previously shown to be part of networks with Efg1
that regulate white-opaque switching and biofilm develop-
ment in C. albicans (Zordan et al., 2007; Nobile et al.,
2012), and others associated with hyphal growth (Lassak
et al., 2011) (Fig. 5).
We used DREME (Bailey, 2011) and FIMO (Grant
et al., 2011) to identify conserved motifs and therefore the
most likely binding site of EFG1 in C. parapsilosis, using
100 bp regions around the peak summits from the ChIP-
seq experiments. Six significant motifs were identified
from both analyses of all 931 promoters (Fig. 6). The
most significant motifs (AYGCRC and CACAAAR) most
closely resemble the binding sites for Dal82 and Ndt80
in S. cerevisiae (Dorrington and Cooper, 1993; Zhu
et al., 2009) (Fig. 6A). The third most significant motif
(CTGCATR) resembles the binding site for Sok2 and
Phd1 from S. cerevisiae (TGCAGNNA) (Harbison et al.,
2004), which are co-orthologues of Efg1. The motif is also
similar to the predicted Efg1 binding sites from C. albi-
cans recently reported by Lassak et al. (2011) (TATG
CATA) and Nobile et al. (2012) (RTGCATRW). The
remaining motifs are similar to binding sites for transcrip-
tion factors with zinc-finger DNA-binding domains, includ-
ing Zap1, which has been implicated in regulation of
biofilm development in C. albicans (Nobile et al., 2009).
All six motifs are present in 40% of the intergenic regions,
putative Efg1 and Ndt80 binding sites are found together
in 70%, and Efg1, Ndt80 and Dal82 sites co-occur in 65%
(Table S4). It is therefore likely that the targets of Efg1 in
C. parapsilosis are also regulated by other transcription
factors.
The intergenic regions bound by Efg1 are significantly
longer than the average intergenic region in C. parapsilo-
sis (average of 1.7 kb compared with 0.6 kb, P value < 2.2
e-16, Welch’s t-test, Fig. 6B). Nobile et al. (2012) previ-
ously found that intergenic regions bound by biofilm
regulators in C. albicans are larger than average, and
suggested that the combination of short regulatory motifs
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Fig. 4. Efg1 is required for virulence.
A. G. mellonella larvae were inoculated with 2 × 106 yeast cells in
PBS, and survival was monitored over time. The strains tested
included wild type (CLIB214), efg1Δ/efg1Δ deletion strains (LCP5
and LCP7), a heterozygote efg1Δ/EFG1 (LCPH1) and the
reintegrant efg1/ACT1-EFG1 strain LCP7_RI. The survival curves
for the efg1Δ/efg1Δ deletion strains are significantly different from
the curves for the wild-type infections (Mantel-Cox test, P-value
< 0.01).
B. Human PBMC-derived macrophages from four independent
donors were co-cultured with C. parapsilosis cells, and the relative
levels of LDH in the media were determined after 48 h. The strains
used are the same as in (A). The levels of damage induced by the
efg1Δ/efg1Δ deletion strains is significantly less than that of the wild
type (two-tailed Wilcoxon text, P-value < 0.05).
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with larger targets for mutations may allow new genes to
be incorporated in a regulatory network.
Identification of the EFG1 regulon
To evaluate the overall biological role of Efg1, we deter-
mined the transcriptional profile of efg1 knockout concen-
tric and smooth cells and compared them to the profile of
wild-type (concentric) cells. We profiled two independent
deletion strains, and included two smooth and three con-
centric samples (Table S5). We compared the expression
of concentric wild-type cells to efg1 deletions in both con-
centric and smooth morphologies (Table S5A). However,
to ensure that the differences we observed are related to
the gene deletion rather than to colony type, we predomi-
nantly analysed the comparison of concentric cells from
both wild-type and efg1 deletion strains.
A total of 353 genes are differentially regulated in con-
centric cells from the efg1 knockout (Table S5). Efg1 acts
as both an activator and a repressor of gene expression;
expression of 167 genes is reduced in the efg1 deletions,
and expression of 186 genes is increased. Approximately
53% of the genes that are differentially expressed (and
60% of the downregulated genes) are also bound by Efg1
(Table S6A). Similar to C. albicans (Tebarth et al., 2003),
Efg1 negatively regulates its own expression. When
the open reading frame is deleted, expression of the 5′
UTR region is increased in both concentric and smooth
cells (Fig. S2). Upregulated genes are enriched in pro-
cesses associated with ergosterol metabolism (Table S5).
However, the promoter regions of most of these genes are
not bound by Efg1, and so they are likely to be regulated
indirectly.
There are significant differences in expression patterns
between the smooth and concentric colonies from
efg1 deletions; 380 genes are differentially expressed
(Table S5B). Genes upregulated in concentric cells are
enriched in processes associated with iron metabolism,
whereas downregulated genes are enriched in metabolism
of amino acid and organic acids. Less than 30% are bound
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Fig. 5. Binding of Efg1 to intergenic regions.
(A)–(F): each represent a different intergenic
region, with the coding sequences marked by
blue boxes where the arrowhead indicates the
direction of transcription. Short gene names
are given where possible; long numbers (e.g.
405390) should be preceded by the identifier
CPAR2. (A) WOR2/CPAR2_405390; (B)
CZF1; (C) BCR1/CPAR_60200; (D)
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The peak with the highest summit fold change
relative to the input in each intergenic region
is indicated in pink. The images were
constructed using the Integrative Genomics
Viewer (IGV) (Robinson et al., 2011).
Sequences within each intergenic region
(indicated by numbered coloured boxes) were
chosen for analysis by ChIP-PCR. The
enrichment of PCR products in
immunoprecipitated samples as a % of the
input samples is plotted. The
average ± standard deviation from three
independent measurements is shown.
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by Efg1, suggesting that differential expression is likely to
be related to morphology, rather than to deletion of EFG1.
Expression of some of the genes with the largest
decreases in expression (which are also bound by Efg1)
were confirmed using quantitative PCR. Expression is
reduced in both concentric and smooth cells (Fig. S3).
Comparison of Efg1 targets in C. parapsilosis and
C. albicans
We compared our ChIP-seq analysis from C. parapsilosis
to the ChIP-chip analysis used to identify Efg1-bound
genes in C. albicans reported by Nobile et al. (2012) and
Lassak et al. (2011). A total of 218 bound genes are shared
with the C. albicans data set from Nobile et al. (2012) and
29 with Lassak et al. (2011) (Table S7, Fig. 7). The shared
targets are enriched for processes associated with fila-
mentous growth, biofilm development, and cell adhesion
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(Table S7C, Fig. 7). Many of the shared targets are tran-
scription factors (Fig. 7), suggesting that some regulatory
networks are conserved in the two species, even if the
biological processes (such as filamentation) are not.
Nobile et al. (2012) suggested that the biofilm regula-
tory network has arisen recently in C. albicans. We con-
firmed that the targets of Efg1 in C. albicans are enriched
for young genes, using a very restricted definition of
genes that appeared on the C. albicans/C. dubliniensis/
C. tropicalis branch (P value = 1.0e-4; Table S3C). In con-
trast, genes bound by Efg1 in C. parapsilosis are not
significantly enriched for young genes (i.e. those arising in
the C. parapsilosis/C. orthopsilosis/Lodderomyces elong-
isporus lineage). The role of Efg1 in C. parapsilosis may
therefore resemble the ancestral role, rather than that
observed in C. albicans.
We attempted to compare the genes differentially
expressed in an efg1 deletion in C. parapsilosis with those
differentially expressed in an equivalent knockout in
C. albicans (Nobile et al., 2012). However, we identified
only 353 differentially expressed genes from C. parapsilo-
sis concentric cells, whereas Nobile et al. (2012) identified
> 3000 in C. albicans, corresponding to half the genome.
Part of the difference is probably because the profiles
described by Nobile et al. (2012) are from biofilm cells. In
contrast, Doedt et al. (2004) detected only 283 genes
differentially expressed in a C. albicans efg1 deletion
grown in similar conditions to ours. Approximately 80 are
also differentially expressed in C. parapsilosis but some
have different patterns of expression (e.g. downregulated
in C. albicans efg1 and upregulated in C. parapsilosis
efg1) (Table S5D).
The comparison of both Efg1-bound and differentially
expressed genes in C. albicans and C. parapsilosis sug-
gests that some pathways are conserved between the two
species, and some are not. Many of the shared compo-
nents are transcription factors, including orthologues
associated with biofilm development (e.g. BCR1, NDT80,
BRG1, TEC1), white-opaque switching (e.g. WOR1,
WOR2, CZF1) and filamentation (e.g. NRG1, SFL1,
UME6) in C. albicans (Liu, 2001; Bauer and Wendland,
2007; Zordan et al., 2007; Nobile et al., 2012; Lohse et al.,
2013) (Fig. 7). However, there are also substantial differ-
ences, particularly in the RNA-seq profiles, suggesting that
many of the targets are species-specific.
Efh1 shares few functions with Efg1
Candida albicans contains a paralogue of EFG1, called
EFH1, that is also a member of the APSES family (Doedt
et al., 2004). We identified an orthologue of EFH1 in C. par-
apsilosis (CPAR2_104660), and deleted both alleles in
two independent strains using the fusion PCR method
(Fig. S1). Deleting EFH1 does not affect biofilm develop-
ment, or growth in the presence of cell wall stress (Fig. S4).
The deletion does not affect switching from concentric
to smooth cells, although a novel colony phenotype
does arise at a low level (approximately 3%, Fig. S4,
Table S1).We also found that deleting both efg1 and efh1
resulted in a phenotype that is indistinguishable from efg1
deletion alone for biofilm development and sensitivity to
cell wall drugs (Fig. S4), and for cell morphology during
growth in normoxic and hypoxic conditions (Table S2).
Discussion
Efg1 is a major regulator of morphogenesis in fungal
species, originally characterized in C. albicans as a regu-
lator of filamentous growth (Stoldt et al., 1997). S. cerevi-
siae has two Efg1 co-orthologues, called Phd1 and Sok2,
and both are involved in the regulation of pseudohyphal
growth (Gimeno and Fink, 1994; Ward et al., 1995; Pan
and Heitman, 2000). The proteins are members of the
APSES family, which contain a novel conserved DNA-
binding domain (KilA-N domain) related to a basic helix-
loop-helix domain that is conserved in many eukaryotic
and bacterial viruses (Marchler-Bauer et al., 2011). Other
members such as StuA in A. nidulans and Asm-1 in Neu-
rospora crassa (filamentous ascomycetes, or Pezizomy-
cotina) also control yeast-hyphal transitions (Miller et al.,
1992; Aramayo et al., 1996). An orthologue from a basidi-
omycete, Ustilago maydis, has recently been associated
with regulation of dimorphic growth in this species
(Garcia-Pedrajas et al., 2010). However, in other species,
theAPSES proteins do not control dimorphism, but instead
regulate processes such as mating and conidiation
(Borneman et al., 2002). A role for APSES proteins in
regulation of development has therefore been conserved
across fungal species, but Borneman et al. (2002) suggest
that regulation of hyphal growth is restricted to species that
divide by budding. This is supported by our analysis;
deleting EFG1 in C. parapsilosis increases pseudohyphal
growth in hypoxic conditions (Fig. 1B, Table S2).
Both Efg1 and Efh1 in C. albicans have KilA-N/APSES
domains (Doedt et al., 2004). However, unlike the two
proteins in S. cerevisiae (Phd1 and Sok2), Efg1 and Efh1
fall into different clades (Fig. 8). PHD1 and SOK2 arose
from an ancient duplication event in the Whole Genome
Duplication clade containing S. cerevisiae (Wolfe and
Shields, 1997), and both are orthologous to C. albicans
EFG1 (Fig. 8). The Efg1/Efh1 proteins are poorly con-
served throughout their entire lengths, and contain
several polyQ regions that may be associated with tran-
scriptional activation. However, the DNA-binding domains
(KilA-N domain) are well conserved, and were used to
construct the phylogenetic tree shown in Fig. 8. Whereas
both Efg1 and Efh1 are present in all the Candida species,
the Efg1 paralogues are similar to the APSES proteins
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from other fungal species, and the Efh1 proteins cluster in
a separate clade that appears to be unique to Candida
(Fig. 8). The Efh1 proteins are also evolving rapidly, as
shown by the long branch lengths in the Efh1 cluster in
Fig. 8, whereas the DNA-binding domains of Efg1 are
remarkably similar (more similar than proteins within the
Saccharomyces clade for example).
The rapid evolution of the Efh1 proteins makes it very
difficult to determine their origin [due to difficulties with
long-branch attraction (Fares et al., 2006)]. However, it is
more likely that Efh1 arose in a common ancestor of the
Candida species, rather than an earlier origin with subse-
quent loss in other fungal clades. The function of Efh1
remains to be determined. EFH1 has little effect on the
Efg1-dependent phenotypes in C. albicans, except that a
double efg1/efh1 deletion forms lateral hyphae faster and
is more filamentous in hypoxic conditions, and that pseu-
dohyphal formation caused by overproduction of EFH1
requires EFG1 (unlike filamentation caused by overpro-
duction of EFG1, which is independent of EFH1) (Doedt
et al., 2004). Efg1 and Efh1 share very few regulatory
targets in C. albicans (Doedt et al., 2004), and we have
shown that in C. parapsilosis, EFH1 does not regulate
response to stress or biofilm development, and the pheno-
type of a double efg1/efh1 mutant is indistinguishable from
an efg1 deletion. The switch from concentric to smooth
colony morphology is also not increased by deleting EFH1,
although a novel colony phenotype is observed at a very
low rate (Fig. S4). EFH1 regulates colonization of the
murine intestinal tract by C. albicans in a commensal
model of infection (White et al., 2007); any similar role in
C. parapsilosis has not been tested.
High-frequency phenotypic switching was first observed
in Candida species in the 1930s (Negroni, 1935; Soll,
2002). The best-characterized system is the white-opaque
switch in C. albicans; switching to opaque cells is required
for efficient mating (Slutsky et al., 1987; Miller and
Johnson, 2002). White and opaque cells have different
transcriptional and metabolic profiles, they respond differ-
ently to phagocytosis, and they exhibit different coloniza-
tion and virulence properties (reviewed in Morschhauser,
2010). Switching is a stochastic process, determined by
the levels of the master regulator Wor1 (Huang et al., 2006;
Srikantha et al., 2006; Zordan et al., 2007). Efg1 is a major
component of the regulatory network (Srikantha et al.,
2000; Doedt et al., 2004; Zordan et al., 2007). Switching is
also affected by chromatin modification (Klar et al., 2001;
Srikantha et al., 2001; Hnisz et al., 2009). White-opaque
switching is probably restricted to C. albicans, C. dublin-
iensis and C. tropicalis (Pujol et al., 2004; Porman et al.,
2011).
Other high-frequency switching systems have been
reported in Candida species; for example in C. albicans
3135A, eight different interchangeable colony morpholo-
gies were described (Slutsky et al., 1985; Ramsey et al.,
1994). Expression of some known virulence factors such
as phospholipases and proteinases varies in the different
phenotypes (Antony et al., 2009). Switching between
unusual colony morphologies has also been reported
in C. tropicalis, C. parapsilosis and C. lusitaniae (Enger
et al., 2001; Miller et al., 2006; Franca et al., 2011), and
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PGUG_02282, Clavispora lusitaniae CLUG_02047 and
CLUG_01623.
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outside the CTG clade, in Candida glabrata and Candida
krusei (Lachke et al., 2000; Arzmi et al., 2012). However,
the underlying regulatory mechanisms have not been
elucidated. We showed here that Efg1, a major regulator
of white-opaque switching in C. albicans, also regulates
colony morphology in C. parapsilosis. The rate of switch-
ing varies between the various efg1 deletion strains
(Table S1), but even the strains with high switching rates
return to wild-type levels when EFG1 is re-introduced.
Concentric and smooth cells deleted for EFG1 have sub-
stantially different expression profiles, enriched for genes
associated with iron metabolism (Table S5). It is therefore
likely that two colony morphologies differ in metabolism,
similar to white/opaque cells of C. albicans.
Efg1 is required for biofilm development in C. albicans,
both in in vitro and in in vivo models (Ramage et al., 2002;
Ricicova et al., 2010; Nobile et al., 2012). Unlike many
other biofilm regulators, Efg1 is required for biofilm devel-
opment in low oxygen and high carbon dioxide, conditions
that mimic systemic infection (Stichternoth and Ernst,
2009). We have shown that deleting EFG1 in C. parapsi-
losis also reduces biofilm formation in vitro (Fig. 2A). In
hypoxic conditions wild-type strains make very little biofilm,
and this is further reduced in the efg1 deletions (not
shown). The defect in vivo is not as pronounced; the view
of a catheter at low magnification shows that the overall
mass is somewhat reduced, but the structure of the biofilm
is essentially unchanged (Fig. 2B). One of the major differ-
ences between C. parapsilosis and C. albicans is that the
former does not form true hyphae. Biofilms formed by
C. albicans consist of a mixture of yeast, pseudohyphal
and hyphal cells; the yeast cells form a basal layer, with
hyphae in the upper layers of the mature biofilm (Baillie and
Douglas, 1999; Blankenship and Mitchell, 2006; Ramage
et al., 2009). C. parapsilosis biofilms in contrast consist of
yeast and pseudohyphal cells only (Ding and Butler, 2007;
Ramage et al., 2009). C. albicans strains with an EFG1
deletion are locked in yeast phase in most growth condi-
tions, including in biofilms (Ramage et al., 2002), and
other mutants with reduced hyphal development also
have reduced biofilm mass (Baillie and Douglas, 1999).
Although the entire biofilm network identified by Nobile
et al. (2012) does not appear to be dependent on hyphal
growth, it is very likely that for the EFG1 deletion some of
the reduction in biofilm development is due to reduced
hyphal formation. The lack of hyphae in C. parapsilosis
may partly explain the difference in phenotype between the
EFG1 deletions in the two species in vivo, where hyphal
growth is likely to be more important for C. albicans
biofilms.
We found that deleting EFG1 in C. parapsilosis results in
attenuated virulence in an insect model, and reduces
damage of human macrophages (Fig. 4). In C. albicans,
reduction in virulence of an efg1 deletion has generally
been related to a failure of the knockout to grow as hyphae
(Lo et al., 1997; Chamilos et al., 2006; Pukkila-Worley
et al., 2009). However, even in models where efg1 strains
do form hyphae (such as gnotobiotic mice deficient in
natural killer and T cells) virulence is greatly reduced
(Westwater et al., 2007). The virulence phenotypes in
C. albicans may therefore be linked to changes in immu-
nogenicity of the efg1 deletion caused by alterations in the
cell wall (Sohn et al., 2003; Doedt et al., 2004; Zavrel et al.,
2012). Deleting EFG1 in C. parapsilosis also affects cell
wall sensitivity (Fig. 3), and some of the genes differentially
expressed in the efg1 deletion (such as orthologues of
WSC2, WSC4, PGA26, PGA30, PGA62, ALS6, ALS7) are
known cell wall proteins in C. albicans (Table S5). The role
of Efg1 in virulence is therefore likely to be conserved in
both species.
There is a substantial overlap between the intergenic
regions bound by Efg1 in C. albicans and C. parapsilosis,
even when the C. albicans experiments were carried out
using biofilm cells (Table S7; Nobile et al., 2012). In both
species the targets are enriched for transcription factors
(Table S3) and 38 of the 93 bound by Efg1 in C. parapsi-
losis are also bound in C. albicans biofilms (Table S7).
These include Wor1, Wor2 and Czf1, which together with
Efg1 control white-opaque switching in C. albicans
(Zordan et al., 2007) (Figs 5 and 7). Most of the biofilm
regulatory network identified by Nobile et al. (2012) is
present (Efg1, Bcr1, Ndt80, Brg1, Tec1) (Fig. 7, Table S3).
Other targets of Efg1 (e.g. Nrg1) that are associated with
the yeast-to-hyphal switch (Lassak et al., 2011) are also
bound by Efg1 in C. parapsilosis (Fig. 7). Efg1 and Ndt80
motifs co-occur in many intergenic regions in C. parapsi-
losis (Table S4). This strongly suggests that the compo-
nents and structure of regulatory networks are highly
conserved in C. albicans and C. parapsilosis. However,
the functions of the networks are not as well conserved. For
example, some of the phenotypes regulated by Efg1 in
C. albicans (such as true hyphal growth and white/opaque
switching) do not occur in C. parapsilosis. In addition, there
is relatively little overlap between genes differentially
expressed in an efg1 deletion in C. parapsilosis and
C. albicans (Table S5D) (Doedt et al., 2004). Even in
biofilm development, where Efg1 is implicated in both
species, many of the targets of the transcription factor are
newly evolved in C. albicans but not in C. parapsilosis
(Table S3C). It is therefore likely that the role of Efg1 in
C. parapsilosis more closely resembles the ancestral
state, and may have been adapted for filamentation, white-
opaque switching and some aspects of biofilm regulation in
C. albicans.
The intergenic regions bound by Efg1 in C. parapsilosis
are significantly longer than the average intergenic region
(Fig. 6B). It has also been reported that targets of Efg1
and other biofilm regulators (Nobile et al., 2012), and of
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Wor1 (Zordan et al., 2007), are longer in C. albicans.
Nobile et al. (2012) suggest that this is partly because the
biofilm targets are relatively young in evolutionary terms,
and young genes tend to have long promoters. However,
the association of promoter size with evolutionary age
comes from an analysis of yeast species from before and
after the whole-genome duplication (WGD) event. New
promoters tend to be longer in post WGD species, but this
is due to loss of genes within intergenic regions that
occurs as part of a major rearrangement following dupli-
cation (Sugino and Innan, 2012). Candida species have
not undergone genome duplication. The long promoters
may be a feature of the number of regulatory proteins that
bind to them; Efg1 appears to be part of many networks,
and many targets are co-regulated. In C. parapsilosis, a
significant number of the Efg1 targets are likely to also
bind Ndt80, and possibly up to five other transcription
factors. In addition, Efg1 binding, although centred on a
short motif, extends over large regions of the promoters
(Fig. 5). Finally, some of the transcription factors have
very long 5′ untranslated regions; for EFG1 in C. albicans,
the 5′UTR extend almost 1200 bp upstream of the start
(Srikantha et al., 2000). Some regulation may therefore
be at the post-translational level.
Efg1 has many roles in C. albicans, including controll-
ing filamentation (Stoldt et al., 1997), hypoxic response
(Stichternoth and Ernst, 2009), regulation of cell wall pro-
teins (Sohn et al., 2003; Zavrel et al., 2012), white-opaque
switch (Morschhauser, 2010), biofilm development
(Ramage et al., 2002; Nobile et al., 2012), generation of
chlamydospores (Sonneborn et al., 1999a), regulation of
metabolism (Doedt et al., 2004) and virulence (Lo et al.,
1997; Chamilos et al., 2006; Pukkila-Worley et al., 2009).
Some of these phenotypes (such as biofilm development,
virulence and sensitivity to cell wall-damaging agents) are
conserved in C. parapsilosis (Figs 2, 3 and 5; Zavrel et al.,
2012). However, there are also significant differences. The
role of Efg1 in biofilm development in C. parapsilosis is not
as dominant as in C. albicans. More importantly, Efg1
circuits that regulate morphological switching in C. parap-
silosis may have been adapted to control white-opaque
switching and filamentation in C. albicans. We look forward
to identifying the other members of the network regulating
concentric-smooth switching, and to explore the roles
of Efg1 and its targets in multiple cellular processes in
C. parapsilosis.
Experimental procedures
Strains and growth conditions
Candida parapsilosis strains were grown in YPD medium (1%
yeast extract, 2% peptone, 2% glucose) at 30°C. For colony
selection 2% agar was added. To select for transformants,
nourseothricin (Werner Bioagents Jena, Germany) was added
to YPD agar at a final concentration of 200 μg ml−1. Transfor-
mants containing the LEU2 and HIS1 markers were selected
on synthetic complete (SC; 0.67% yeast nitrogen base, 2%
dextrose, 0.075% mixture of amino acids, 2% agar) media
without leucine or histidine. For biofilm formation, C. parapsi-
losis was grown in synthetic defined (SD) medium (0.67%
yeast nitrogen base) containing 50 mM glucose. Calcofluor
white M2R (Sigma-Aldrich), caspofungin (from Cancidas,
Merck & Co.) and Sodium n-Dodecyl Sulphate (SDS) (Bio-
sciences) were added to the medium at the desired concen-
trations. For phenotype screening 500 μl of an overnight
culture was washed and resuspended in phospho-buffered
(PBS) at a concentration of 6.25 × 105 cells ml−1. A fivefold
serial dilution was generated and 3 μl was plated onto selected
agar plates, and incubated at 30°C for 3 days. The strains and
oligonucleotides used are listed in Table S8 and Table S9
respectively. All hypoxia experiments were carried out at 37°C
in 1% O2 in an InVivo2 400 hypoxia chamber. For microscopy,
cells were taken straight from colonies on an agar plate and
resuspended in 10 μl of 2 mM Calcofluor White. Images were
taken using a Zeiss AxioImager M1 fluorescent microscope.
All gene constructs are described in Fig. S1.
Determination of switching rate
Colonies of C. parapsilosis strains with specific morphologies
were isolated and grown overnight in 5 ml YPD at 30°C,
shaking at 200 r.p.m. One millilitre of overnight cultures was
washed twice in PBS and diluted to ∼ 100 cells per 100 μl in
PBS. One hundred microlitres of the diluted sample was
spread on a YPD plate. YPD plates were incubated under
various temperatures and under normoxic and hypoxic con-
ditions. Multiple plates were used so that > 1000 colonies
were counted from each phenotype under each growth con-
dition. The plates were inspected after 2 days, 3 days and 4
days. Colonies were counted on day three to determine
switching frequencies (Table S1).
Biofilm assays
Overnight cultures of C. parapsilosis strains grown in 5 ml
YPD at 30°C were washed twice in 1 ml PBS buffer and
diluted to an A600 of 1 in SD medium with 50 mM glucose. One
millilitre of each culture was added to three wells of a 24-well
Nunc Delta plate (Thermo Scientific) and incubated on a
shaker (50 r.p.m.) at 37°C for 2 h (initial adhesion phase).
The culture was removed and each well was washed once
with 1 ml PBS buffer. One millilitre of fresh SD medium with
50 mM glucose was added to each well and the plates were
shaken at 37°C for an additional 48 h. The culture was
removed and wells were washed twice with 1 ml PBS buffer
and allowed to dry at room temperature overnight. Biofilms
were stained for 30 min with 500 μl of 0.4% (w/v) crystal
violet. Crystal violet was removed and biofilms were washed
twice with 1 ml PBS buffer and dried overnight at room tem-
perature. The resulting biofilms were then photographed. For
dry weight measurements of biofilms 5 ml of cultures at an
A600 of 1 in SD medium with 50 mM glucose were inoculated
in each well of six-well Nunc plates. Biofilms were allowed
develop as above. After 48 h the wells were washed twice
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with 2 ml PBS buffer. One millilitre PBS buffer was added to
each well and biofilm was scraped from the bottom of each
well. Biofilm from two wells was combined, filtered using a
0.8 μm Millipore filter, dried for 48 h at room temperature
and weighed. In vivo biofilms assays were carried out as
described previously (Ding et al., 2011).
Host damage assay
Human peripheral blood mononuclear cells (PBMCs) were
isolated from buffy coats of healthy donors by Ficoll Paque
PLUS (GE Healthcare) density gradient centrifugation, as
described elsewhere (Schlenke et al., 1998). Experiments
were performed according to the institutional regulation of the
independent ethics committee of the University of Szeged.
Isolated PBMCs were suspended in RPMI medium (LONZA)
supplemented with 1% 100× Penicillin-Streptomycin solution
(Sigma-Aldrich), and plated in 96-well cell culture plates
(5 × 105 PBMC per well, in 100 μl) to isolate monocytes by
plastic adherence. After 2 h of incubation (37°C, 5% CO2,
100% relative humidity), floating cells were removed, and the
attached monocytes were gently washed with PBS. The iso-
lated cells were cultured for 7 days in X-VIVO 15 serum-free
medium (LONZA) supplemented with 1% 100× Penicillin-
Streptomycin solution (Sigma-Aldrich), in the presence of
10 ng ml−1 human recombinant GM-CSF (Sigma-Aldrich) to
enable macrophage differentiation. Host-cell damaging
capacity of C. parapsilosis strains was determined by LDH
(lactate dehydrogenase) activity assay. PBMC-DM (PBMC-
derived macrophage) cells were co-cultured with C. parapsi-
losis cells at a ratio of 1:5 in X-VIVO 15 serum-free medium
(LONZA) supplemented with 1% 100× Penicillin-Streptomycin
solution for 24 or 48 h, or left unstimulated (negative control).
Macrophage cells alone incubated under identical conditions
were applied as negative controls. LDH in medium from cul-
tures containing uninfected and infected tissues at 24 and 48 h
was measured using the Cytotoxicity Detection Kit (LDH;
Roche) according to the manufacturer’s instructions. Relative
LDH activity was calculated, as described previously (Gacser
et al., 2007).
Galleria mellonella survival assay
Infection of G. mellonella larvae (Mous Livebait R.J., the Neth-
erlands) was performed as described previously (Mylonakis,
2008; Garcia-Rodas et al., 2011). Briefly, larvae were inocu-
lated with 10 μl of a C. parapsilosis suspension prepared in
PBS containing 2 × 106 yeast cells by an injection in the last left
pro-leg, using a 26-gauge needle with Hamilton syringes.After
injection, caterpillars were incubated at 25°C, and the number
of dead larvae was noted daily. In each experiment, a group of
caterpillars were left without any manipulation (untreated
control), and another group of caterpillars was inoculated with
PBS only.
ChIP-seq and ChIP-PCR analysis
To introduce a tag just before the stop codon of Efg1, the MYC
epitope tag and C. albicans HIS1 gene were amplified by PCR
from plasmid pFA-MYC-CaHIS1 (Lavoie et al., 2008) using
primers EFG1_tag_F and EFG1_tag_R (Table S9). The puri-
fied product was transformed by electroporation into C. par-
apsilosis LCPH3 and LCPH4 (EFG1/efg1::LEU2, his1−/his1−)
generating strains LCP3M and LCP4M. Correct integration of
the tag was confirmed by PCR screening (Fig. S1).
Cultures were prepared for chromatin immunoprecipitation
as described by Aparicio et al. (2005), from C. parapsilosis
cells grown in YPD to an A600 = 1. Samples were sonicated
using a Biorupter™ (Diagenode) for 15 min at 30 s intervals
at high power setting in an ice bath. The ice was then
changed and the sonication was repeated. Input samples
before the addition of antibody were used as control. Regions
bound to Efg1 were immunoprecipitated using a mouse
monoclonal antibody (Myc-tag 9B11, Cell Signaling). Three
input (before immunoprecipitation) and three immunoprecipi-
tated samples were used (Table S10).
All ChIP-seq libraries were generated according to the
Illumina protocol (Illumina Guide Part # 11257047 Rev. A). A
limited 18-cycle amplification of size-selected libraries was
carried out. To eliminate adapter dimers libraries were further
sized selected using a 2.5% TAE agarose gels. Purified librar-
ies were quantified using a Qubit™ fluorometer (Invitrogen)
and a Quant-iT™ double-stranded DNA High-Sensitivity
Assay Kit (Invitrogen). Clustering and sequencing of the
material was carried out as per manufacturer’s instructions
on the Illumina GAIIx platform in the UCD Conway Institute.
On average, 22.5 million 42 bp reads were obtained from
each sample (Table S10).
The reads from the three experimental samples and the
three controls were mapped to the latest version C. parapsi-
losis genome (Guida et al., 2011) using BWA (Li and Durbin,
2009). More than 90% of reads for each library were aligned to
the reference (Table S10). Approximately 6.5% of reads from
the immunoprecipitated samples and 1.2% of reads from the
controls mapped to the rDNAlocus. The BinaryAlignment/Map
(BAM) files were sorted and indexed using SAMtools (Li et al.,
2009). Binding sites were predicted using MACS 2.0 (Zhang
et al., 2008) (Feng et al., 2012), with a q-value threshold of
0.01 and automatic estimation of reads per genomic location.
Fragment size was estimated using the SPP package
(Kharchenko et al., 2008). Each immunoprecipitated sample
was individually compared with the three merged controls. The
reproducibility of the data sets was determined by pairwise
comparisons of the three samples using IDR (Irreproducible
Discovery Rate method), as recommended by the Encode
consortium (Landt et al., 2012) and implemented in the SPP
package (Kharchenko et al., 2008). A maximum of 1246 rep-
licable peaks were identified. The MACS2 analysis was then
repeated using the merged samples as input and called peaks
were ranked by P value, using a False Discovery Rate (FDR)
threshold of 1%. The top 1246 peaks were selected.
A custom Python pipeline was used to associate peaks
with genes in the latest C. parapsilosis annotation (Guida
et al., 2011). Peaks were mapped to the gene with the
nearest 5′ end. Peaks lying in a divergent promoter region
were assigned to both genes. Peaks lying between two con-
vergent genes were not assigned. Peaks completely within a
coding region were also not assigned. In total, 1155 peaks
were assigned to 931 intergenic regions. Overall, these map
to 536 unique promoters and 395 divergent promoters. Peaks
were ranked by π value (Xiao et al., 2012), i.e. a product of
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P-values and fold enrichment at peak summit position with
respect to the control. Where there were multiple peaks in a
promoter, only the peak with the highest rank was considered
(Table S3).
To confirm the peaks identified by ChIP-seq analysis, quan-
titative real-time PCR was carried out using three independent
input and three immunoprecipitated samples from strains
LCP3M and LCP4M. Primers were designed to amplify
regions of high and low enrichment of Efg1 identified in the
ChIP-seq experiments using Primer3Plus software (http://
www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi)
(Table S9). For each reaction, a mastermix consisting of 5 μl
2× Brilliant III SYBR® green (Applied Biosystems), 500 nM of
each primer, 0.15 μl ROX reference dye (diluted 1:500),
2.35 μl Nuclease free H2O and 1 μl of DNA (Input or Immuno-
precipitated sample) was used. Samples were analysed in
duplicate on a Strategene Mx3005P QPCR system (Agilent
Technologies) using cycling conditions of one cycle at 95°C for
3 min followed by 40 cycles at 95°C for 10 s, 60°C for 20 s and
a final cycle of 95°C for 1 min followed by melting curve
analysis at 55°C to 95°C (temperature transition, 0.2°C s−1)
with stepwise fluorescence detection. Enrichment in the pro-
moter regions was calculated as the percentage of PCR
product from the average of the immunoprecipitated samples
normalized to the average of the input samples.
Motif prediction was carried out using the online version of
DREME (Bailey, 2011) using 100 bp sequences around the
summits of the best peak for each intergenic region for all
samples. Shuffled input sequences were used for back-
ground comparison. Significant results were submitted to
TOMTOM (Gupta et al., 2007) using default parameters.
Motif occurrence was confirmed using FIMO with a signifi-
cance threshold of 1e-03 (Grant et al., 2011).
RNA-seq analysis
RNA-seq library preparation for strand-specific sequencing
was carried out essentially as described in Guida et al.
(2011), from cultures grown in YPD. We used HTSeq and
DESeq (Anders and Huber, 2010) to compare 17.7 × 106
36 bp Illumina reads from three samples of wild type (C. par-
apsilosis CLIB214) to 15 × 106 reads from two different efg1
deletion strains in the smooth phenotype and 16.4 × 106
reads from three deletions of the concentric phenotype
(Table S10). Reads with exceptionally high coverage (rDNA)
were masked. The RNA-seq data sets were submitted to the
Gene Expression Omnibus (GEO) (series GSE41065). All
Gene Ontology analysis was carried out at the Candida
Genome Database (Inglis et al., 2012).
Gene age analysis
A total of 585 genes present in the C. albicans, C. dubliniensis
and C. tropicalis and not in other CTG clade species were
designated as ‘young’ on the C. albicans branch, whereas 473
genes present only in the C. parapsilosis, C. orthopsilosis and
L. elongisporus branch were designated ‘young’ in C. parap-
silosis. Gene orthology was defined using the Candida Gene
Order Browser (version 29 August 2012) (Fitzpatrick et al.,
2010; Maguire et al., 2013). Differences between observed
and expected values in the list of Efg1-bound genes were
determined using Fisher’s exact test (Table S3C).
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